新闻中心

News Center

Eight Disciplines of Foncoo Pharmaceutical's "Integrity Culture" Work

Release Time

2022-06-22 10:31

General principle: Use power for personal gain and private transactions are like cancer, not to be removed, or even worse, enough to destroy a company. The eight disciplines of "honest culture" are the "high-voltage line" of Foncoo Pharmaceuticals. Once employees violate the rules, they will be unconditionally dismissed.

1. Don't bother customers: You are not allowed to take the initiative to ask customers to pick up, arrange accommodation, arrange play, etc.

2. Do not spend customer fees: do not take the initiative to invite customers to dinner; eat alone with customers, pay the bill by employees or take turns AA. It is not allowed to accept gifts and money of more than 1,000 yuan from customers. Any expenses that should be paid by individuals are not allowed to be reimbursed at the client's unit.

3. Do not extort customers: In commercial transactions, it is not allowed to violate fair trade, directly or indirectly imply customers, ask customers for favors, valuables, etc.

4. It is not allowed to use customers for personal gain: it is not allowed to ask customers for the market or the hospital to sell medicines; it is not allowed to privately borrow, transfer, and buy goods from customers; it is not allowed to ship goods in the name of customers; it is not allowed to collude with customers Fake goods; it is not allowed to require customers to remit money to an account under the personal name without the permission of the company.

5. The superior shall not accept bribes from the inferior: The superior shall not accept any property and valuables of more than 200 yuan from the inferior for any purpose.

6. Subordinates are not allowed to bribe their superiors: any employee of the company is not allowed to bribe their superiors, and gifts cannot exceed 200 yuan.

7. No abuse of power and corruption: All employees must act in accordance with the regulations. In all procurement and business activities of the company, no abuse of power, false public welfare, favoritism and fraud are allowed. ”; No employee is allowed to take advantage of his position to embezzle company property or misappropriate public funds.

8. It is not allowed to conceal the company: It is not allowed to conceal that the company recommends relatives and friends to join the company. The company welcomes public recommendation.

The above behaviors are supervised by all staff and customers, and a special complaint mailbox for the general manager is set up: fclj@foncoo.com

Related News

Foncoo Pharmaceutical participated in the 19th National Psychiatry Academic Conference of the Chinese Medical Association

Sponsored by the Chinese Medical Association and the Psychiatry Branch of the Chinese Medical Association, and organized by the Chongqing Medical Association, the Psychiatry Branch of the Chongqing Medical Association, the First Affiliated Hospital of Chongqing Medical University, and the University City Hospital Affiliated to Chongqing Medical University The conference and the Academic Conference on Child and Adolescent Psychiatry were successfully held at Chongqing Yuelai International Conference Center from December 21 to 24, 2021.

2022-05-25

图片名称

2021-Foncoo Public Welfare

On October 15, 2021, Foncoo Pharmaceutical donated 100,000 yuan in cash to the "Gu Xueqiu Pharmacy Education Fund" public welfare student aid project of the Beijing Renren Public Welfare Foundation-Shenyang Pharmaceutical University.

2022-05-25

图片名称

Foncoo Pharmaceutical's corporate culture 5.0 was officially released

Official announcement! Seriously, don't be distracted!

2022-05-25

图片名称

Foncoo Pharmaceutical participated in the 16th National Academic Conference on Psychiatric Hospital Management

On October 29-31, 2021, the 16th National Academic Conference on Psychiatric Hospital Management, hosted by the Chinese Hospital Association and the Chinese Hospital Association Psychiatric Hospital Branch, was held in Chongqing.

2022-05-25

图片名称

"Bupropion Hydrochloride Sustained-Release Tablets (II)" exclusively sold by Foncoo Pharmaceuticals was approved in China

Recently, "Bupropion Hydrochloride Sustained-Release Tablets (II) (150mg, 300mg)", exclusively sold by Pangu Pharmaceuticals (Mainland China), was approved by the State Drug Administration and deemed to have passed the consistency evaluation. The product, developed by Shanghai Xuantai Pharmaceuticals, was previously approved by the FDA in August 2017 and was marketed in the United States.

2022-05-25

图片名称

Foncoo Pharmaceutical participated in the 9th China Schizophrenia Forum

From October 22 to 24, 2021, the "Ninth China Schizophrenia Forum" was grandly held in Wuhan. The theme of this forum is "Infection, Inflammation and Schizophrenia".

2022-05-25

图片名称